Reactive oxygen species in cancer stem cells of head and neck squamous cancer

Leemans, 2011, The molecular biology of head and neck cancer, Nat. Rev. Cancer, 11, 9, 10.1038/nrc2982 Qian, 2015, Biology and immunology of cancer stem(-like) cells in head and neck cancer, Crit. Rev. Oncol. Hematol., 95, 337, 10.1016/j.critrevonc.2015.03.009 Albers, 2012, Stem cells in squamous head and neck cancer, Crit. Rev. Oncol. Hematol., 81, 224, 10.1016/j.critrevonc.2011.03.004 Chen, 2011, Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma, PloS One, 6, e16466, 10.1371/journal.pone.0016466 Liao, 2013, Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines, J. Cancer Res. Clin. Oncol., 139, 159, 10.1007/s00432-012-1311-2 Qian, 2013, ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status, Oncol. Rep., 29, 1777, 10.3892/or.2013.2340 Qian, 2014, Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma, J. Cancer Res. Clin. Oncol., 140, 1151, 10.1007/s00432-014-1685-4 Dong, 2017, Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: a meta-analysis, PloS One, 12, e0187615, 10.1371/journal.pone.0187615 Vlashi, 2016, Radiation-induced dedifferentiation of head and neck cancer cells into cancer stem cells depends on human papillomavirus status, Int. J. Radiat. Oncol. Biol. Phys., 94, 1198, 10.1016/j.ijrobp.2016.01.005 Milanovic, 2017, Senescence-associated reprogramming promotes cancer stemness, Nature Cerutti, 1985, Prooxidant states and tumor promotion, Science, 227, 375, 10.1126/science.2981433 Behrend, 2003, Reactive oxygen species in oncogenic transformation, Biochem. Soc. Trans., 31, 1441, 10.1042/bst0311441 Wu, 2006, The signaling mechanism of ROS in tumor progression, Cancer Metastasis Rev., 25, 695, 10.1007/s10555-006-9037-8 Kim, 2008, Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells, Int. J. Cancer. J. Int. du Cancer, 122, 672, 10.1002/ijc.23158 Renschler, 2004, The emerging role of reactive oxygen species in cancer therapy, Eur J. Cancer, 40, 1934, 10.1016/j.ejca.2004.02.031 Yamagishi, 2005, Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation, Int. J. Tissue React., 27, 189 Prasad, 2016, ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines, Oncotarget, 7, 79388, 10.18632/oncotarget.12692 Trachootham, 2009, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nat. Rev. Drug Discov., 8, 579, 10.1038/nrd2803 He, 2017, Inhibiting ROS-NF-kappaB-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma, Food Chem. Toxicol., 101, 55, 10.1016/j.fct.2017.01.002 Fan, 2016, Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma, Oncotarget, 7, 59691, 10.18632/oncotarget.10836 Nor, 2014, Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer, Neoplasia, 16, 137, 10.1593/neo.131744 Jiang, 2017, RXRalpha enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC), Carcinogenesis Diehn, 2009, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature, 458, 780, 10.1038/nature07733 Kim, 2012, Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon, Ann. Surg. Oncol., 19, S539, 10.1245/s10434-011-2040-5 Chang, 2014, Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity, Cancer Res., 74, 6291, 10.1158/0008-5472.CAN-14-0626 Circu, 2010, Reactive oxygen species, cellular redox systems, and apoptosis, Free Radic. BiolB Med., 48, 749, 10.1016/j.freeradbiomed.2009.12.022 Wells, 2009, Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer, Toxicol. Sci., 108, 4, 10.1093/toxsci/kfn263 Vaquero, 2004, Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells, J. Biol. Chem., 279, 34643, 10.1074/jbc.M400078200 Turrens, 2003, Mitochondrial formation of reactive oxygen species, J. Physiology, 552, 335, 10.1113/jphysiol.2003.049478 Dequanter, 2017, Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy, Onco Targets Ther., 10, 259, 10.2147/OTT.S118980 Dequanter, 2013, Assessment of oxidative stress in tumors and histologically normal mucosa from patients with head and neck squamous cell carcinoma: a preliminary study, Eur. J. Cancer Prev., 22, 558, 10.1097/CEJ.0b013e32836056dc Gupta, 2012, Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy, Antioxid. Redox Signal, 16, 1295, 10.1089/ars.2011.4414 Hampton, 1997, Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis, FEBS Lett., 414, 552, 10.1016/S0014-5793(97)01068-5 Wu, 2007, Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound, Cancer Biol. Ther., 6, 646, 10.4161/cbt.6.5.4092 Zhang, 2016, Reactive oxygen species and targeted therapy for pancreatic cancer, Oxid. Med. Cell Longev., 2016, 1616781, 10.1155/2016/1616781 Lin, 2017, Reactive oxygen species and colorectal cancer, J. Cell. Physiol. De Santis, 2018, Signaling pathways regulating redox balance in cancer metabolism, Front. Oncol., 8, 126, 10.3389/fonc.2018.00126 Mercurio, 1999, NF-kappaB as a primary regulator of the stress response, Oncogene, 18, 6163, 10.1038/sj.onc.1203174 Ahmadian, 2017, Anti-cancer effects of citalopram on hepatocellular carcinoma cells occur via cytochrome c release and the activation of NF-kB, Anticancer Agents Med. Chem., 17, 1570, 10.2174/1871520617666170327155930 Zhang, 2016, ROS and ROS-mediated cellular signaling, Oxid. Med. Cell Longev., 2016, 4350965, 10.1155/2016/4350965 Wu, 2017, Ginsenoside Rh4 induces apoptosis and autophagic cell death through activation of the ROS/JNK/p53 pathway in colorectal cancer cells, Biochem. Pharmacol. Castro-Caldas, 2012, Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway, Mol. Neurobiol., 45, 466, 10.1007/s12035-012-8266-9 Adler, 1999, Regulation of JNK signaling by GSTp, EMBO J., 18, 1321, 10.1093/emboj/18.5.1321 Sundaresan, 1995, Requirement for generation of H2O2 for platelet-derived growth factor signal transduction, Science, 270, 296, 10.1126/science.270.5234.296 Guyton, 1996, Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury, J. Biol. Chem., 271, 4138, 10.1074/jbc.271.8.4138 Rao, 1996, Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity, J. Biol. Chem., 271, 27760, 10.1074/jbc.271.44.27760 Song, 2017, Dioscin induces gallbladder cancer apoptosis by inhibiting ROS-mediated PI3K/AKT signalling, Int. J. Biol. Sci., 13, 782, 10.7150/ijbs.18732 Zhu, 2016, The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells, Toxico. Lett., 264, 79, 10.1016/j.toxlet.2016.11.006 Zhang, 2017, Cigarette smoke extract induces EGFR-TKI resistance via promoting EGFR signaling pathway and ROS generation in NSCLC cell lines, Lung Cancer, 109, 109, 10.1016/j.lungcan.2017.05.011 Guo, 2017, NOX2-ROS-HIF-1alpha signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferation, Biomed. Pharmacother., 85, 733, 10.1016/j.biopha.2016.11.091 Huang, 2016, Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways, Autophagy, 12, 999, 10.1080/15548627.2016.1166318 Kim, 2006, N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells, Oncogene, 25, 2785, 10.1038/sj.onc.1209303 Korde, 2011, Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma, Oncology, 80, 382, 10.1159/000329811 Maehata, 2010, Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells, Free Radic. Res., 44, 913, 10.3109/10715762.2010.490836 Park, 2016, 5-lipoxygenase mediates docosahexaenoyl ethanolamide and n-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells, BMC Cancer, 16, 458, 10.1186/s12885-016-2499-3 Lu, 2009, Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis, Cell Res., 19, 802, 10.1038/cr.2009.69 Maillet, 2012, Redox regulation of p53, redox effectors regulated by p53: a subtle balance, Antioxid. Redox Signal, 16, 1285, 10.1089/ars.2011.4434 Skinner, 2012, TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence, Clin. Cancer Res., 18, 290, 10.1158/1078-0432.CCR-11-2260 Pietka, 2008, Mitochondrial DNA mutations in the pathogenesis in the head and neck squamous cell carcinoma, Otolaryngol. Pol., 62, 158 Ishikawa, 2008, ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis, Science, 320, 661, 10.1126/science.1156906 Sun, 2009, Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma, Clin. Cancer Res., 15, 476, 10.1158/1078-0432.CCR-08-0930 Qin, 2017, Coexpression of growth differentiation factor 11 and reactive oxygen species in metastatic oral cancer and its role in inducing the epithelial to mesenchymal transition, Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 123, 697, 10.1016/j.oooo.2017.03.010 Rhyu, 2005, Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells, J. Am. Soc. Nephrol., 16, 667, 10.1681/ASN.2004050425 Rhyu, 2012, Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells, Transpl. Proc., 44, 625, 10.1016/j.transproceed.2011.12.054 Zhang, 2009, Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition, Cancer Res., 69, 5340, 10.1158/0008-5472.CAN-09-0112 Cannito, 2008, Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells, Carcinogenesis, 29, 2267, 10.1093/carcin/bgn216 Dong, 2007, Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells, Braz. J. Med. Biol. Res. = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica … [et al.], 40, 1071 Jin, 2010, Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species, Cancer Res., 70, 2516, 10.1158/0008-5472.CAN-09-3950 Radisky, 2005, Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability, Nature, 436, 123, 10.1038/nature03688 Coso, 2012, NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts, Antioxid. Redox Signal, 16, 1229, 10.1089/ars.2011.4489 Chen, 2012, Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production, Mol. Oncol., 6, 62, 10.1016/j.molonc.2011.11.003 Zheng, 2014, Biliverdin’s regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer, Br. J. Cancer, 110, 2116, 10.1038/bjc.2014.98 Chen, 2016, Reactive oxygen species regulate t cell immune response in the tumor microenvironment, Oxid. Med. Cell Longev., 2016, 1580967, 10.1155/2016/1580967 Shrihari, 2017, Dual role of inflammatory mediators in cancer, Ecancermedicalscience, 11, 721, 10.3332/ecancer.2017.721 Kesarwani, 2013, Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease, Antioxid. Redox Signal., 18, 1497, 10.1089/ars.2011.4073 Wei, 2015, Myeloid-derived suppressor cells in major depression patients suppress T-cell responses through the production of reactive oxygen species, Psychiatry Res., 228, 695, 10.1016/j.psychres.2015.06.002 Liu, 2015, Norepinephrine-induced myeloid-derived suppressor cells block T-cell responses via generation of reactive oxygen species, Immunopharmacol. Immunotoxicol., 37, 359, 10.3109/08923973.2015.1059442 Rodic, 2018, Reactive oxygen species (ROS) are a key determinant of cancer’s metabolic phenotype, Int. J. Cancer, 142, 440, 10.1002/ijc.31069 Hirschhaeuser, 2011, Lactate: a metabolic key player in cancer, Cancer Res., 71, 6921, 10.1158/0008-5472.CAN-11-1457 Sattler, 2010, Glycolytic metabolism and tumour response to fractionated irradiation, Radiother. Oncol., 94, 102, 10.1016/j.radonc.2009.11.007 Krupar, 2018, Immunometabolic determinants of chemoradiotherapy response and survival in head and neck squamous cell carcinoma, Am. J. Pathol., 188, 72, 10.1016/j.ajpath.2017.09.013 Krupar, 2014, Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different, Virchows Archiv, 465, 299, 10.1007/s00428-014-1630-6 Chen, 2013, Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma, Cancer Lett., 338, 47, 10.1016/j.canlet.2012.06.013 Driessens, 2012, Defining the mode of tumour growth by clonal analysis, Nature, 488, 527, 10.1038/nature11344 Yang, 2012, RAC1 activation mediates Twist1-induced cancer cell migration, Nat. Cell Biol., 14, 366, 10.1038/ncb2455 Krishnamurthy, 2010, Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells, Cancer Res., 70, 9969, 10.1158/0008-5472.CAN-10-1712 Campos, 2012, Endothelial derived factors inhibit anoikis of head and neck cancer stem cells, Oral Oncol., 48, 26, 10.1016/j.oraloncology.2011.09.010 Xu, 2012, Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer, Eur. J. Cancer, 48, 1682, 10.1016/j.ejca.2011.12.029 Koukourakis, 2012, Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer, Br. J. Cancer, 106, 846, 10.1038/bjc.2012.33 Chen, 2009, Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer, Biochem. Biophys. Res. Commun., 385, 307, 10.1016/j.bbrc.2009.05.048 Reers, 2014, Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance, Oral Oncol., 50, 155, 10.1016/j.oraloncology.2013.12.006 Zhang, 2010, A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy, Cancer Lett., 289, 151, 10.1016/j.canlet.2009.08.010 Pervaiz, 2009, Oxidative stress regulation of stem and progenitor cells, Antioxid. Redox Signal, 11, 2777, 10.1089/ars.2009.2804 Li, 2011, Stem cell quiescence, Clinical Cancer Res., 17, 4936, 10.1158/1078-0432.CCR-10-1499 Tothova, 2007, FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress, Cell, 128, 325, 10.1016/j.cell.2007.01.003 Ishimoto, 2011, CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth, Cancer Cell, 19, 387, 10.1016/j.ccr.2011.01.038 Simon, 2008, The role of oxygen availability in embryonic development and stem cell function, Nat. Rev. Mol. Cell. Biol., 9, 285, 10.1038/nrm2354 Yeung, 2011, Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells, Proc. Natl. Acad. Sci. U. S. A., 108, 4382, 10.1073/pnas.1014519107 Li, 2017, GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway, Oncotarget, 8, 1508, 10.18632/oncotarget.13649 Pasto, 2014, Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation, Oncotarget, 5, 4305, 10.18632/oncotarget.2010 Song, 2015, FOXM1-induced PRX3 regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function, Gastroenterology, 149, 1006, 10.1053/j.gastro.2015.06.007 Ye, 2011, Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells, Int. J. Cancer, 129, 820, 10.1002/ijc.25944 Tamada, 2012, Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells, Cancer Res., 72, 1438, 10.1158/0008-5472.CAN-11-3024 Yan, 2016, Mitochondria: an intriguing target for killing tumour-initiating cells, Mitochondrion, 26, 86, 10.1016/j.mito.2015.12.007 Shen, 2015, Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma, Cell cycle, 14, 86, 10.4161/15384101.2014.974419 Hou, 2018, Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis, Cell Death Dis., 9, 89, 10.1038/s41419-017-0159-4 Ye, 2011, Heterogeneity of mitochondrial membrane potential: a novel tool to isolate and identify cancer stem cells from a tumor mass?, Stem Cell Rev., 7, 153, 10.1007/s12015-010-9122-9 Landen, 2010, Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer, Mol. Cancer Ther., 9, 3186, 10.1158/1535-7163.MCT-10-0563 Vasiliou, 2000, Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism, Chem. Biol. Interact., 129, 1, 10.1016/S0009-2797(00)00211-8 Koppaka, 2012, Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application, Pharmacol. Rev., 64, 520, 10.1124/pr.111.005538 Kim, 2017, Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor, Oncotarget, 8, 52345, 10.18632/oncotarget.17017 Wang, 2003, Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines, Int J. Cancer, 104, 504, 10.1002/ijc.10972 Lovborg, 2006, Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram, Int. J. Cancer, 118, 1577, 10.1002/ijc.21534 Nechushtan, 2015, A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer, Oncologist, 20, 366, 10.1634/theoncologist.2014-0424 Huang, 2016, A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy, J. Neurooncol., 128, 259, 10.1007/s11060-016-2104-2 Chiba, 2014, Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners, PloS One, 9, e84807, 10.1371/journal.pone.0084807 Han, 2015, Disulfiram inhibits TGF-beta-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-kappaB/Snail pathway, Oncotarget, 6, 40907, 10.18632/oncotarget.5723 Johansson, 1992, A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites, Acta Psychiatr. Scand. Suppl., 369, 15, 10.1111/j.1600-0447.1992.tb03310.x Liu, 2014, Liposome encapsulated disulfiram inhibits NFkappaB pathway and targets breast cancer stem cells in vitro and in vivo, Oncotarget, 5, 7471, 10.18632/oncotarget.2166 Wang, 2016, Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells, Nanomedicine Marcazzan, 2018, Nanomedicine, an emerging therapeutic strategy for oral cancer therapy, Oral Oncol., 76, 1, 10.1016/j.oraloncology.2017.11.014 Nishiyama, 2003, Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice, Cancer Res., 63, 8977 Makino, 2015, cRGD-installed polymeric micelles loading platinum anticancer drugs enable cooperative treatment against lymph node metastasis, J. Control Release, 220, 783, 10.1016/j.jconrel.2015.10.017 Murakami, 2011, Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting, Sci. Transl. Med., 3, 64ra2, 10.1126/scitranslmed.3001385 Miyano, 2017, cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells, J. Control Release, 261, 275, 10.1016/j.jconrel.2017.06.021 Wang, 2013, Effects of poly(L-lysine)-modified Fe3O4 nanoparticles on endogenous reactive oxygen species in cancer stem cells, Biomaterials, 34, 1155, 10.1016/j.biomaterials.2012.10.063 Tzur-Balter, 2015, Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues, Nat. Commun., 6, 6208, 10.1038/ncomms7208 McDonnell, 2005, Supramolecular photonic therapeutic agents, J. Am. Chem. Soc., 127, 16360, 10.1021/ja0553497 Shen, 2017, pH-responsive aerobic nanoparticles for effective photodynamic therapy, Theranostics, 7, 4537, 10.7150/thno.19546 Chen, 2004, Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy, Oral Oncol., 40, 630, 10.1016/j.oraloncology.2003.12.010 Yu, 2014, Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells, PloS One, 9, e87129, 10.1371/journal.pone.0087129 Dolmans, 2003, Photodynamic therapy for cancer, Nat. Rev. Cancer, 3, 380, 10.1038/nrc1071 Usacheva, 2014, Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles, Mol. Pharm., 11, 3186, 10.1021/mp5003619 Qian, 2015, Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety, SpringerPlus, 4, 208, 10.1186/s40064-015-0988-5 Albers, 2017, Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck, Mol. Clin. Oncol., 7, 151, 10.3892/mco.2017.1281 Abhold, 2012, EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells, PloS One, 7, e32459, 10.1371/journal.pone.0032459 Cassell, 2010, Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma, Expert Opin. Investig. Drugs, 19, 709, 10.1517/13543781003769844 Cohen, 2009, Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck, Oral Oncol., 45, e155, 10.1016/j.oraloncology.2009.05.637 Vermorken, 2007, J. Clin. Oncol., 25, 2171, 10.1200/JCO.2006.06.7447 Yu, 2017, Anticancer effect of polyphyllin iota in colorectal cancer cells through ROS-dependent autophagy and G2/M arrest mechanisms, Nat. Prod. Res., 1 Zou, 2017, Induction of reactive oxygen species: an emerging approach for cancer therapy, Apoptosis, 22, 1321, 10.1007/s10495-017-1424-9 Muramatsu, 2013, Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course, Hepatology, 58, 218, 10.1002/hep.26345 Svendsen, 2011, Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma, Acta Neuropathol., 122, 495, 10.1007/s00401-011-0867-2 Jamal, 2010, Microenvironmental regulation of glioblastoma radioresponse, Clin. Cancer Res., 16, 6049, 10.1158/1078-0432.CCR-10-2435 Achuthan, 2011, Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species, J. Biol. Chem., 286, 37813, 10.1074/jbc.M110.200675 Yip, 2011, Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties, Br. J. Cancer, 104, 1564, 10.1038/bjc.2011.126 Herault, 2012, A role for GPx3 in activity of normal and leukemia stem cells, J. Exp. Med., 209, 895, 10.1084/jem.20102386 Gammon, 2013, Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism, PloS One, 8, e62493, 10.1371/journal.pone.0062493 Kim, 2013, Low production of reactive oxygen species and high DNA repair: mechanism of radioresistance of prostate cancer stem cells, Anticancer Res., 33, 4469 Lopez, 2012, Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance, BMC Cancer, 12, 48, 10.1186/1471-2407-12-48 Mizuno, 2015, Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species, Gynecol. Oncol., 137, 299, 10.1016/j.ygyno.2014.12.005